Biblio

Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
5
Ivanoff, S., Gruson, B., Chantepie, S.P., Lemasle, E., Merlusca, L., Harrivel, V., Charbonnier, A., Votte, P., Royer, B., and Marolleau, J.-P. (2013). 5-azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy.Am J Hematol.
Yang, T., Lin, Q., Ren, J., Chen, P., Yuan, X., Luo, X., Liu, T., Zheng, J., Zheng, Z., Zheng, X., et al. (2016). A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.Oncotarget.
Zhang, J., Cui, Y., Li, X., Xiao, Y., Liu, L., Jia, F., He, J., Xie, X., Parthasarathy, S., Hao, H., et al. (2020). 5F peptide promotes endothelial differentiation of bone marrow stem cells through activation of ERK1/2 signaling.Eur J Pharmacol173051.
Xu, Z.-Y., Tang, J.-N., Xie, H.-X., Du, Y.-A., Huang, L., Yu, P.-F., and Cheng, X.-D. (2015). 5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells.Int J Biol Sci11, 284-294.
Su, M., Kirchner, A., Stazzoni, S., Müller, M., Wagner, M., Schröder, A., and Carell, T. (2016). 5-Formylcytosine Could Be a Semipermanent Base in Specific Genome Sites.Angew Chem Int Ed Engl.
Uribe-Lewis, S., Stark, R., Carroll, T., Dunning, M.J., Bachman, M., Ito, Y., Stojic, L., Halim, S., Vowler, S.L., Lynch, A.G., et al. (2015). 5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer.Genome Biol16, 69.
Takaki, M., Goto, K., and Kawahara, I. (2014). The 5-hydroxytryptamine 4 Receptor Agonist-induced Actions and Enteric Neurogenesis in the Gut.J Neurogastroenterol Motil20, 17-30.
Gordeeva, O., and Safandeev, V. (2019). 5-Hydroxytryptophan (5-HTP)-induced intracellular syndrome in mouse non-neural embryonic cells is associated with inhibited proliferation and cell death.Neuropharmacology107862.
Kaut, O., Kuchelmeister, K., Moehl, C., and Wüllner, U. (2018). 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease.J Chem Neuroanat.

Pages